UB Paderborn / Katalog / Suche / in CDI

Beyond Kras: MYC Rules in Pancreatic Cancer

Cellular and molecular gastroenterology and hepatology, 2018-01, Vol.6 (2), p.223-224

Korc, Murray, MD

2018

Link zum Volltext

Verfügbarkeit prüfen

14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness

Clinical cancer research, 2008-12, Vol.14 (23), p.7614-7623

2008

Link zum Volltext

Verfügbarkeit prüfen

Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis

Cellular and molecular gastroenterology and hepatology, 2016-03, Vol.2 (2), p.118-119

Korc, Murray, MD

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract C31: The glycosaminoglycan syndecan-4 facilitates pancreatic cancer progression and biologic aggressiveness

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (24_Supplement), p.C31-C31

2019

Link zum Volltext

Verfügbarkeit prüfen

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis

Gastroenterology research, 2017-08, Vol.10 (4), p.224-234

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice

Molecular therapy. Methods & clinical development, 2018-03, Vol.8 (C), p.8-20

2018

Link zum Volltext

Verfügbarkeit prüfen

Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer

Diabetes care, 2011-09, Vol.34 (9), p.1965-1971

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2951: DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2951-2951

2013

Link zum Volltext

Verfügbarkeit prüfen

Causes and Consequences of Aberrant TGF-β Signaling in Pancreatic Cancer

Journal of the Medical Association of Nippon Medical School, 2015-10, Vol.11 (4), p.207-207

Murray Korc

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2917: Differentiation therapy and the mechanisms that terminate malignant proliferation

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2917-2917

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4079: Perturbations in tat-interacting protein 30 (TIP30) levels contribute to pancreatic cancer aggressiveness

Cancer research (Chicago, Ill.), 2018, Vol.78 (13_Supplement), p.4079-4079

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4433: RB mediates TGF-β effects on growth inhibition and invasion in pancreatic cancer cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4433-4433

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3055: PD-0332991, a selective cyclin-dependent-kinase 4/6 Inhibitor, upregulates multiple genes promoting invasion and metastasis in pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3055-3055

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 177: MiR-10b promotes migration and invasion in pancreatic cancer cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.177-177

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4257: Integrated network analysis reveals potentially novel molecular pathways mechanism and therapeutic targets of pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4257-4257

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2449: FGFR4 inhibitor BLU9931 induces cellular senescence in pancreatic ductal adenocarcinoma cell lines promoting sensitivity to senolytic therapy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2449-2449

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3400: An angiogenesis gene signature points to active TGF-betaJAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3400-3400

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3400: An angiogenesis gene signature points to active TGF-beta/JAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3400-3400

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4862: Protein arginine methyltransferase 5 as a tumor promoter and therapeutic target in gastrointestinal cancers

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4862-4862

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4180: TGF-beta promotes angiogenesis in an RB-deficient, Kras-driven mouse model of pancreatic cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4180-4180

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract B19: Redox factor 1 (Ref-1) signaling in the interaction between pancreatic tumor cells and cancer-associated fibroblasts

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13_Supplement), p.B19-B19

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-MET co-expressing metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS4157-TPS4157

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2811: GPC1 promotes tumor growth and angiogenesis in a KrasG12D- Driven mouse model of pancreatic cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2811-2811

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 969: TGF-beta cross-talks with the EGF receptor family to promote proliferation of pancreatic cancer cells with dysfunctional RB

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.969-969

2014

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-[beta] to promote proliferation.(Corrigendum)(Correction notice)

The Journal of clinical investigation, 2016-07, Vol.126 (7), p.2774

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Beyond Kras: MYC Rules in Pancreatic Cancer

14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness

Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis

Abstract C31: The glycosaminoglycan syndecan-4 facilitates pancreatic cancer progression and biologic aggressiveness

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice

Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer

Abstract 2951: DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine

Causes and Consequences of Aberrant TGF-β Signaling in Pancreatic Cancer

Abstract 2917: Differentiation therapy and the mechanisms that terminate malignant proliferation

Abstract 4079: Perturbations in tat-interacting protein 30 (TIP30) levels contribute to pancreatic cancer aggressiveness

Abstract 4433: RB mediates TGF-β effects on growth inhibition and invasion in pancreatic cancer cells

Abstract 3055: PD-0332991, a selective cyclin-dependent-kinase 4/6 Inhibitor, upregulates multiple genes promoting invasion and metastasis in pancreatic ductal adenocarcinoma

Abstract 177: MiR-10b promotes migration and invasion in pancreatic cancer cells

Abstract 4257: Integrated network analysis reveals potentially novel molecular pathways mechanism and therapeutic targets of pancreatic ductal adenocarcinoma

Abstract 2449: FGFR4 inhibitor BLU9931 induces cellular senescence in pancreatic ductal adenocarcinoma cell lines promoting sensitivity to senolytic therapy

Abstract 3400: An angiogenesis gene signature points to active TGF-betaJAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors

Abstract 3400: An angiogenesis gene signature points to active TGF-beta/JAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors

Abstract 4862: Protein arginine methyltransferase 5 as a tumor promoter and therapeutic target in gastrointestinal cancers

Abstract 4180: TGF-beta promotes angiogenesis in an RB-deficient, Kras-driven mouse model of pancreatic cancer

Abstract B19: Redox factor 1 (Ref-1) signaling in the interaction between pancreatic tumor cells and cancer-associated fibroblasts

A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-MET co-expressing metastatic pancreatic adenocarcinoma

Abstract 2811: GPC1 promotes tumor growth and angiogenesis in a KrasG12D- Driven mouse model of pancreatic cancer

Abstract 969: TGF-beta cross-talks with the EGF receptor family to promote proliferation of pancreatic cancer cells with dysfunctional RB

Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-[beta] to promote proliferation.(Corrigendum)(Correction notice)

Aktive Filter

Suchergebnisse filtern